Drug Trial Radar · NCT05219968
Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults
Last checked: Nov 19, 2026Latest source record: May 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
196
Actual
Start
Jan 27, 2022
Primary completion
Mar 4, 2024
Study completion Sep 16, 2024
Sponsor
- Lead sponsor
- Lyra TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multicenter, phase III, randomized, blinded, controlled, parallel group with safety extension phase with crossover or continued treatment.
Conditions
- Chronic Sinusitis
- Chronic Rhinosinusitis (Diagnosis)
Interventions
LYR-210Drug
LYR-210 drug matrix (mometasone furoate)
Sham procedure controlDrug
Sham procedure control
Background TherapyOther
Daily Saline Irrigation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline (CFBL) in the 7-day Average Composite Score of 3 Cardinal Symptoms (3CS) in Participants Without Nasal Polyps.Time frame: 24 Weeks
Locations
55 sites in 5 countries. Site status is shown where the registry gives one.
Lyra Investigational Site
Birmingham, Alabama
Lyra Investigational Site
Escondido, California
Lyra Investigational Site
La Mesa, California
Lyra Investigational Site
Sacramento, California
Lyra Investigational Site
Torrance, California
Lyra Investigational Site
Boca Raton, Florida
Lyra Investigational Site
Boynton Beach, Florida
Lyra Investigational Site
Plantation, Florida
Lyra Investigational Site
Port Saint Lucie, Florida
Lyra Investigational Site
Chicago, Illinois
Lyra Investigational Site
Louisville, Kentucky
Lyra Investigational Site
Baltimore, Maryland
Lyra Investigational Site
New Hyde Park, New York
Lyra Investigational Site
New York, New York
Lyra Investigational Site
New York, New York
Lyra Investigational Site
New York, New York
Lyra Investigational Site
Winston-Salem, North Carolina
Lyra Investigational Site
Charleston, South Carolina
Lyra Investigational Site
Spartanburg, South Carolina
Lyra Investigational Site
Nashville, Tennessee
Lyra Investigational Site
Fort Worth, Texas
Lyra Investigational Site
Houston, Texas
Lyra Investigational Site
Mansfield, Texas
Lyra Investigational Site
San Antonio, Texas
Lyra Investigational Site
South Ogden, Utah
Lyra Investigational Site
Norfolk, Virginia
Lyra Investigational Site
Graz, Austria
Lyra Investigational Site
Klagenfurt, Austria
Lyra Investigational Site
Linz, Austria
Lyra Investigational Site
Vienna, Austria
Lyra Investigational Site
Brno, Czechia
Lyra Investigational Site
Hradec Králové, Czechia
Lyra Investigational Site
Motol, Czechia
Lyra Investigational Site
Olomouc, Czechia
Lyra Investigational Site
Prague, Czechia
Lyra Investigational Site
Bydgoszcz, Poland
Lyra Investigational Site
Bydgoszcz, Poland
Lyra Investigational Site
Elblag, Poland
Lyra Investigational Site
Katowice, Poland
Lyra Investigational Site
Krakow, Poland
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.